Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

Osman Ozel,1 Caila B Vaughn,1 Svetlana P Eckert,1 Dejan Jakimovski,2 Alexis A Lizarraga,1 Bianca Weinstock-Guttman1 1Jacobs MS Center for Treatment and Research, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA; 2Bu...

Full description

Bibliographic Details
Main Authors: Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA, Weinstock-Guttman B
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:Patient Related Outcome Measures
Subjects:
multiple sclerosis
patient-reported outcomes
outcome measures
quality of life
dimethyl fumarate
Online Access:https://www.dovepress.com/dimethyl-fumarate-in-the-treatment-of-relapsing-remitting-multiple-scl-peer-reviewed-article-PROM

Internet

https://www.dovepress.com/dimethyl-fumarate-in-the-treatment-of-relapsing-remitting-multiple-scl-peer-reviewed-article-PROM

Similar Items